Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Breast Neoplasms 1

Interventions

Cytarabine 52Methotrexate 33Cyclophosphamide 33Daunorubicin 29Gene Expression Profiling 27Flow Cytometry 23Vincristine 22Mercaptopurine 19Dexamethasone 19Asparaginase 19Filgrastim 18Microarray Analysis 16Etoposide 16Radiotherapy 15Thioguanine 14Prednisone 14Leucovorin 14Idarubicin 13Polymerase Chain Reaction 12Peripheral Blood Stem Cell Transplantation 12Gemtuzumab 12Doxorubicin 12pegaspargase 10Hydrocortisone 10Calcium Dobesilate 10Busulfan 10Reverse Transcriptase Polymerase Chain Reaction 9Mitoxantrone 9Granulocyte Colony-Stimulating Factor 9Cytogenetic Analysis 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia × valspodar × Clear all
NCT00004217 2015-03-06

S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

SWOG Cancer Research Network

Phase 2 Completed
55 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡